Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (301-310 of 740) with videos related to

Pageof 74
Sort By:
Journal of Cellular and Molecular Medicine|February 18, 2009
Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivoSylvianna Georgaki, Margarita Skopeliti, Marinos Tsiatas, et al.
The Lancet. Oncology|October 12, 2010
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continuesMichel Delforge, Joan Bladé, Meletios A Dimopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment of Waldenström's macroglobulinemia with rituximabMeletios A Dimopoulos, Constantinos Zervas, Athanassios Zomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancerAmanda Psyrri, Mohamad Kassar, Ziwei Yu, et al.
American Journal of Hematology|May 9, 2012
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agentsAnna Tasidou, Maria Roussou, Evangelos Terpos, et al.
Life (Basel, Switzerland)|October 23, 2021
Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy IndividualsEvangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, et al.
Gynecologic Oncology|May 3, 2005
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceDimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos, et al.
BMC Medical Genetics|January 23, 2019
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic optionsMyrto Moutafi, Dimitrios C Ziogas, Spyros Michopoulos, et al.
Gynecologic Oncology|December 8, 2004
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter studyMeletios A Dimopoulos, Christos Papadimitriou, Georgios Hamilos, et al.
BMC Cancer|September 27, 2006
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology GroupAristotle Bamias, Christos Papadimitriou, Eleni Efstathiou, et al.
Pageof 74

Showing results (301-310 of 740) with videos related to

Sort By:
Pageof 74
Journal of Cellular and Molecular Medicine|February 18, 2009
Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivoSylvianna Georgaki, Margarita Skopeliti, Marinos Tsiatas, et al.
The Lancet. Oncology|October 12, 2010
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continuesMichel Delforge, Joan Bladé, Meletios A Dimopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Treatment of Waldenström's macroglobulinemia with rituximabMeletios A Dimopoulos, Constantinos Zervas, Athanassios Zomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancerAmanda Psyrri, Mohamad Kassar, Ziwei Yu, et al.
American Journal of Hematology|May 9, 2012
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agentsAnna Tasidou, Maria Roussou, Evangelos Terpos, et al.
Life (Basel, Switzerland)|October 23, 2021
Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy IndividualsEvangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, et al.
Gynecologic Oncology|May 3, 2005
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experienceDimitrios Pectasides, George Fountzilas, Gerasimos Aravantinos, et al.
BMC Medical Genetics|January 23, 2019
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic optionsMyrto Moutafi, Dimitrios C Ziogas, Spyros Michopoulos, et al.
Gynecologic Oncology|December 8, 2004
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter studyMeletios A Dimopoulos, Christos Papadimitriou, Georgios Hamilos, et al.
BMC Cancer|September 27, 2006
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology GroupAristotle Bamias, Christos Papadimitriou, Eleni Efstathiou, et al.
Pageof 74